Long-acting contraceptive designed to be self-administered via microneedle patch

Published on January 14, 2019

A new long-acting contraceptive designed to be self-administered by women may provide a new family planning option, particularly in developing nations where access to healthcare can be limited, a recent study suggests. The contraceptive would be delivered using microneedle skin patch technology originally developed for the painless administration of vaccines.

Read Full Article (External Site)